Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Quantification of Tau-A in serum after brain injury: a comparison of two analytical platforms, ELISA and electrochemiluminescence immunoassay

Research output: Contribution to journalJournal articlepeer-review

  1. Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study

    Research output: Contribution to journalJournal articlepeer-review

  2. Melatonin profile in healthy, elderly subjects - A systematic literature review

    Research output: Contribution to journalReviewpeer-review

  3. Is the TOAST Classification Suitable for Use in Personalized Medicine in Ischemic Stroke?

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

BACKGROUND: Previous studies have indicated the utility of the ADAM10-generated fragment of tau, Tau-A, as marker of neuronal damage. However, the sensitivity of the ELISA-based system was limited.

OBJECTIVES: We utilized the extensive dynamic range of electrochemiluminescence compared to colorimetric assessment to improve the sensitivity of the Tau-A assay and investigate Tau-A levels after brain injury.

METHODS: We converted the Tau-A competitive ELISA to a competitive electrochemiluminescence-based immunoassay, Tau-A ECLIA, and compared the methods by measuring serum samples in a TBI (n = 40) and a stroke cohort (n = 64).

RESULTS: The Tau-A ECLIA was technically robust. Only 1% of the samples was below the detection limit in the ECLIA compared to 10.6% in the ELISA . Tau-A measured in both assays could discriminate between patients with a TBI and non-trauma controls (ELISA: p = 0.0005, ECLIA: p = 0.0002). The increased dynamic range of the Tau-A ECLIA also allowed discrimination between healthy controls from patients with hemorrhagic (p = 0.0172) and severe ischemic stroke (p = 0.0118) respectively, as well as patients with mild ischemic stroke from severe (p = 0.0445).

CONCLUSIONS: The Tau-A ECLIA was characterized by dynamic range compared to the ELISA, which facilitated a better separation between the patient groups. Tau-A warrants further investigation as a neuronal injury associated marker.

Original languageEnglish
JournalBrain Injury
Issue number6
Pages (from-to)792-799
Number of pages8
Publication statusPublished - 12 May 2022

    Research areas

  • electrochemiluminescence immunoassay, serum biomarker, stroke, Tau-A fragment, traumatic brain injury

ID: 78348606